The tweet was deleted by the author.
But we saved everything 🙂.
Edgewise Therapeutics will take part in the 10th International Cardiovascular Genomic Medicine & SickKids Cardiac Precision Medicine Conference in Toronto. The company acts as a sponsor for this significant gathering.
The event brings together experts to delve into advancements and discussions around cardiovascular genomics and precision medicine. Edgewise Therapeutics, an established name in therapeutics development, utilizes this opportunity to highlight its commitment to precision medicine.
The conference, associated with the GenomFoundation and SKCardPrecision, is expected to foster collaboration and exchange of cutting-edge research in genomic medicine.
Edgewise Therapeutics' focus on advancing genomic medicine at the Toronto conference mirrors the company’s sustained engagement in global scientific dialogue, as seen in its earlier presentation of muscular dystrophy research at the World Muscle Society conference in Vienna. This continuity underscores the firm's commitment to fostering innovation across rare and cardiometabolic diseases.